Literature DB >> 4168443

A new method of active immunisation to autologous human tumour tissue.

P L Wolf, J Vazquez, N P Czajkowski, M Rosenblatt.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 4168443     DOI: 10.1016/s0140-6736(67)90229-2

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  12 in total

Review 1.  [The immunology of malignant melanoma (author's transl)].

Authors:  G Schieferstein
Journal:  Klin Wochenschr       Date:  1978-03-15

Review 2.  Cell cooperation in the immune response.

Authors:  J H Playfair
Journal:  Clin Exp Immunol       Date:  1971-06       Impact factor: 4.330

3.  Immunotherapy of cancer.

Authors: 
Journal:  Can Med Assoc J       Date:  1968-03-16       Impact factor: 8.262

4.  Immunity to malignant disease in man.

Authors:  G H Fairley
Journal:  Br Med J       Date:  1969-05-24

Review 5.  Immunology of bronchial carcinoma.

Authors:  D A Evans
Journal:  Thorax       Date:  1976-10       Impact factor: 9.139

6.  Specific cancer immunotherapy adjunctive to surgery for advanced gastric cancer: a report of six long term survivors.

Authors:  Y Ishikawa; M Fukushima; S Machida; H Kakuta; T Nishikawa; S Fukuda
Journal:  Gastroenterol Jpn       Date:  1978

Review 7.  Tumour immunology and the gut.

Authors:  K C Calman
Journal:  Gut       Date:  1975-06       Impact factor: 23.059

8.  Immunologic response of cancer patients modified by immunization with tumor vaccine.

Authors:  L J Humphrey; B Boehm; W R Jewell; O R Boehm
Journal:  Ann Surg       Date:  1972-10       Impact factor: 12.969

9.  Histological evidence of tumour rejection after active immunotherapy in human malignant disease.

Authors:  G Taylor; J L Odili
Journal:  Br Med J       Date:  1972-04-22

10.  Regulation of the immune response: suppressive and enhancing effects of passively administered antibody.

Authors:  C S Pincus; M E Lamm; V Nussenzweig
Journal:  J Exp Med       Date:  1971-05-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.